A solid phase enzyme immunoassay for erythropoietin which required only a small specimen of blood was evaluated. It permitted measurement up to 150 IU/L. Recovery was between 86.2% and 110-0% and between-batch precision between 4.7% and 5.7%. We determined the levels of erythropoietin in infants aged 10 months (geometric mean 11-2 IU/L; 95% range 3.6-34.9) and in children aged 2 years (geometric mean 10.5 IU/L; 95% range 4.3-25-8). Both were significantly higher than the values found in children aged 4 years (geometric mean 7 -2 IU/L; 95% range 2-4-21 -8). There were no differences between the values in children at 4 years, those aged 4-15 years and adults.
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Erythropoietin (EPO), a glycoprotein hormone of renal origin, is the primary regulator of erythrocyte production and differentiation. Deficiency of erythropoietin has been considered to be the major factor in the pathogenesis of the anaemia of chronic renal failure.' Recently, administration of human erythropoietin derived from recombinant DNA has resulted in complete correction of the anaemia of renal disease in haemodialysis patients. 2 The production of large amounts of highly purified recombinant erythropoietin allowed the development of specific and sensitive radio-immunoa~says;~ so several groups have studied erythropoietin in plasma or serum from adults and from a large group of children in different situations: premature infant^,^ children with sickle cell diseases-6 and children with Fanconi's hypoproliferative anaemia.6 The main purpose of this study was to estimate plasma erythropoietin by a solid phase immunoassay in a group of 130 healthy children as a basis for further clinical studies in pathological conditions such as anaemia or renal disease.
MATERIAL § AND METHOD §
The subjects of this study were a group of 130 Correspondence: Dr Monique Pressac. children aged between 10 months and 15 years. There were 46 girls and 84 boys. The children under 4 years were participants in a health examination at the Childhood Health Centre. This group was subdivided into three subgroups of 34 infants aged 10 months, 30 preschool children aged 2 years and 37 other children aged 4 years. Those from 4 to 15 years were attending the Otorhinolaryngology Department of our hospital as ambulatory outpatients for minor ear, nose or throat problems. All were considered healthy from a haematological and iron-status standpoint by determinations of haemoglobin, mean corpuscular volume, transferrin, iron and plasma ferritin. Blood was centrifuged and serum or plasma was stored at -20 "C until thawed for analysis. A group of 69 healthy adults, 47 women and 22 men served as an adult control group.
Erythropoietin was estimated by a solid phase immunoassay method from Bio-Merieux (69280 Marcy L'Etoile, France). It is a sandwich technique using two monoclonal antibodies: a mouse antihuman erythropoietin antibody coated to polystyrene tubes, and a mouse erythropoietin antibody-peroxidase conjugate. Human erythropoietin standards and control were from Bio-Merieux. The amount of EPO was expressed in international units (IU) equivalent to native EPO, a urinary EPO preparation (2nd I.R.P.). The relationship between IU and mass showed that 345 Statistical evaluation of the goodness of fit of our data groups to Gaussian or log-Gaussian distributions was performed using the Kolmogorov-Smirnov test. The confidence level was set at P < 0-05. Log-Gaussian groups were compared by the t-test using log-transformed data. TABLE 
with measurement of erythropoietin concentration

Concentration
Erythropoietin Substance tested (g/L) measured (IU/L) 9.4 9.2 9.5 9.2 9.2 9.5 8.8 8.9 9.1 9.2 9.1 9.8
Substances tested f o r potential interference
Detection limit
The lowest concentration of erythropoietin significantly different from the zero standard value with a probability of 95% was 1 IU/L.
Specificity
Homology of rEPO with native urinary EPO has been verified by the amino acid sequence' and by the structure of carbohydrate chains.8 Serum, urinary or recombinant EPO have the same immunological b e h a v i o~r ;~ these authors found a complete agreement of the dose-response curves of rEPO and urinary EPO, and complete absorption of serum EPO with antiserum prepared against rEPO.
We verified these results by dilution tests with serum or urine from patients and preparations of recombinant erythropoietin. No interference was observed by haemoglobin (Table l) , or by bilirubin, creatinine, vitamin C, glutathione, sodium citrate, sodium fluoride, ammonium oxalate and heparin ( Table 2 ).
Linearity and reproductibility
The standard curve permitted measurement of EPO concentrations up to 150 IU/L. Specimens giving values above 150 IU/L were diluted 10-fold with the 'zero' standard. We assessed within-run precision by analysing 30 aliquots of each of three different plasma specimens. We assessed betweenrun precision by analysing one aliquot of each of the three pooled specimen of plasma on 30 consecutive working days. The results are presented in Table 3 .
Recovery of added erythropoietin
Five human plasmas to which erythropoietin had been added at concentrations of 5 , 15, 50 and 150IU/L were assayed for EPO ( Table 4 ). Recovery of erythropoietin was found to be between 86.2 and 110% with an erythropoietin concentration which did not differ significantly from the theoretical value. The high dose hook 
Reference values
Erythropoietin values in adults and in the different groups of children were log-normally distributed.
Normal adults
Plasma erythropoietin values gave a geometric mean of 7.5 IU/L with a range of 3-7-15-2 IU/L calculated from log-transformed values.
Children
Estimates of erythropoietin for the whole group of 130 children ranged from 2.4 to 34-9 IU/L ( Fig. 1) . There was no difference between the normalized mean erythropoietin concentrations in boys and girls ( Table 5 ) .
Plasma erythropoietin values at 10 months, 2 years, 4 years and above 4 years are presented in Table 6 . There were no significant differences between the geometric means of the 10 months and 2 year groups and the 4 year and above 4 year groups. The group (10 months-2 years) with a mean of 12-1 IU/L was compared with the group (4-15 years) with a mean of 8 -9 I U / L ; the difference was statistically significant with P<O-OOl. Likewise, the mean of first group was significantly higher (P<O-OoOl) than the mean found in adults (8-2 IU/L).
Haemoglobin (Hb) showed the age-related changes typical of normal childhood and correlated with MCV (r=0-61). There was no relation between erythropoietin and Hb (P= 0.2; Fig. 2 ). Table 7 . In our data, the mean of group 10 months-2 years (12-1 IU/L) was significantly higher than the adult control group (8-2 IU/L); our findings contrast with those reported by Hellebostad et al. lo who used the radioimmunoassay method of Egrie and Lane" with the 2nd International Reference Preparation (IRP) of erythropoietin as standard. They gave the limits of normal for infants and children aged between 3 months and 16 years as about 9.1-27.6 IU/L (mean: 15.8). These authors found that EPO concentrations were essentially constant throughout childhood, and the same as those in the adult group; however, in a small group of very young children age 2.8-3.5 months, the mean erythropoietin concentration was 17-6IU/L with a range of In a study of 14 healthy Nigerian children aged between 6.5 and 22 months, Wickramasinghe et al. I3 found an average EPO concentration of 80 IU/L which was considerably higher than that of 22 IU/L obtained by the same technique of radioimmunoassay in 8 1 healthy Caucasian adults aged between 20 and 69 years. This confirms our observation that older infants and young children have higher serum erythropoietin levels than adults.
DISCUSSION
12-38 IU/L. No workers have reported a difference between EPO concentrations in boys and girls; in the adult groups, the EPO level has not been found to vary significantly with age and, more often than not, the mean value was significantly higher in females than in male^.^.'^ The enzyme immunoassay method we used gave values similar to but somewhat lower than other published values. Using an RIA method with an anti-recombinant E P O antibody, Haga et al. I6 obtained normal human values similar to those presented here, but there are several publications in which values for normal human E P O concentrations were significantly higher than ours.9-10-14*15 All these authors used a radioimmunoassay with an anti-recombinant E P O antibody and the 2nd IRP of E P O as standard.
Overall, estimates of E P O in samples from normal children and adults show relatively close agreement between assays, as reviewed by Cotes,12 who reported that mean estimates from different laboratories ranged from 12.6 to 29 IU/L.
In practice, the absolute value obtained with a specific assay system is not as significant as the ability to demonstrate appropriate relative changes in EPO concentration correlated with physiological and clinical conditions.
Despite the absence of a correlation between EPO and haemoglobin it appears that, in infants aged 10 months-2 years, a concentration of E P O higher than that in children over 2 years was found in conjunction with the relative low haemoglobin concentration present at this age ( 7 -4 ? 0 -9 mmol/L) compared with adult values In conclusion, determination of erythropoietin in the healthy children by this enzyme immunoassay method gave values which varied with age but not with sex. The reference values in children were approximately similar to other published values.
